-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BSgNBnRPXSrbm1L+svIYEQCt34hZ1iWx3DvVHrqqeOFMPC5UEZFFcivMe5/9mixU cObSqltbrmTLEyWkSzdEKg== 0000217028-03-000003.txt : 20030923 0000217028-03-000003.hdr.sgml : 20030923 20030923141402 ACCESSION NUMBER: 0000217028-03-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030923 FILED AS OF DATE: 20030923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AVENTIS INC CENTRAL INDEX KEY: 0000217028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25323 FILM NUMBER: 03905774 BUSINESS ADDRESS: STREET 1: 500 ARCOLA RD STREET 2: P O BOX 1200 M/S 5B14 CITY: COLLEGEVILLE STATE: PA ZIP: 19426-0107 BUSINESS PHONE: 6104548000 FORMER NAME: FORMER CONFORMED NAME: RHONE POULENC RORER INC DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: RORER GROUP INC DATE OF NAME CHANGE: 19900731 FORMER NAME: FORMER CONFORMED NAME: RORER AMCHEM INC DATE OF NAME CHANGE: 19770604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBANY MOLECULAR RESEARCH INC CENTRAL INDEX KEY: 0001065087 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 141742717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 CORPORATE CIRCLE STREET 2: P O BOX 15098 CITY: ALBANY STATE: NY ZIP: 12203-5154 BUSINESS PHONE: 5184640279 MAIL ADDRESS: STREET 1: 21 CORPORATE CIRCLE STREET 2: P O BOX 15098 CITY: ALBANY STATE: NY ZIP: 12203-5154 4 1 primary_doc.xml PRIMARY DOCUMENT X0201 4 2003-09-23 1 0001065087 ALBANY MOLECULAR RESEARCH INC AMRI 0000217028 AVENTIS INC 300 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 0 0 0 1 Less than 10% Owner On December 31, 2001, in a corporate restructuring, Aventis Holdings Inc. acquired direct ownership of Issuer's shares from its affilite, Aventis Pharmaceutcals Inc. As of such date, as a result of an increase in the number of Issuer's shares that were outstanding, Aventis Holdings Inc. was not an owner of more than 10% of the Issuer's shares. Aventis Inc. beneficially owns the shares of Issuer's common stock that are directly owned by its direct subsdiary, Aventis Holdings Inc. Correction to Item 7 - Report is filed by more than One Reporting Person. /s/Gerald P. Belle, President 2003-09-23 EX-99 3 alb_jfi.txt JOINT FILER INFORMATION Joint Filer Information Name: Aventis Holdings Inc. Address: 3711 Kennett Pike, Suite 200 Greenville, Delaware 19807 Designated Filer: Aventis Inc. Issuer: Albany Molecular Research Inc. Nature of Interest: Direct Date of Event Requiring Statement: September 23, 2003 Signature: /s/ Joseph M. Palladino -----END PRIVACY-ENHANCED MESSAGE-----